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In classical Mendelian inheritance, each parent
donates a set of chromosomes to its offspring so
that maternally and paternally encoded information
is expressed equally. The phenomena of X-chromo-
some inactivation (XCI) and autosomal imprinting in
mammals violate this dogma of genetic equality. In
XCI, one of the two female X chromosomes is
silenced to equalize X-linked gene dosage between
XX and XY individuals. In genomic imprinting,
parental marks determine which of the embryo’s two
autosomal alleles will be expressed. Although XCI
and imprinting appear distinct, molecular evidence
now shows that they share a surprising number of
features. Among them are cis-acting control centers,
long-distance regulation and differential DNA methy-
lation. Perhaps one of the most intriguing similari-
ties between XCI and imprinting has been their
association with noncoding and antisense RNAs.
Very recent data also suggest the common involve-
ment of histone modifications and chromatin-asso-
ciated factors such as CTCF. Collectively, the
evidence suggests that XCI and genomic imprinting
may have a common origin. Here, I hypothesize that
the need for X-linked dosage compensation was a
major driving force in the evolution of genomic
imprinting in mammals. I propose that imprinting
was first fixed on the X chromosome for XCI and
subsequently acquired by autosomes.
Introduction
Every living species faces the problem of regulating
gene dosage. The expression of just the right dose is
central to the execution of developmental programs
and to the ability of an organism to respond to new
environmental stimuli. Known methods of gene regu-
lation roughly fall into two classes. In the ‘symmetric’
class, both alleles of a given gene are equally modu-
lated. This is very common and includes regulation of
the globin locus [1] and c-fos [2], and dosage com-
pensation of the X chromosomes in the nematode
Caenorhabditis elegans [3]. In the ‘asymmetric’ class,
the two alleles are differentially regulated such that
one allele is expressed at a lower level or is altogether
silenced (reviewed in [4]). 
For genes in the asymmetric class, there must be a
way of coordinating expression between two alleles. X
chromosome inactivation (XCI) and autosomal imprint-
ing epitomize this type of regulation (reviewed in [5–9]).
It is estimated that XCI and autosomal imprinting
restrict the expression of approximately 5–10% of the
mammalian genome. Because disrupting XCI has
lethal consequences [10] and disrupting imprinting
often leads to severe growth anomalies and inviability
for the developing embryo [8], it is believed that these
epigenetic mechanisms arose in part to deal with the
problem of dosage in developmentally sensitive genes.
XCI was first described in 1961 by Mary Lyon [11]
who, from studying coat color variegation in mice,
concluded that one of the two X chromosomes must
be randomly silenced in each cell of female mice.
She hypothesized that this process of whole chro-
mosome inactivation evolved to balance transcrip-
tional dosage between XX females and XY males.
XCI is now known to be coordinated by the cis-
acting X inactivation center Xic [12], which controls
most, if not all, of the steps of XCI, including the
counting of Xs, the choice of one X for silencing, and
the initiation and spread of heterochromatin along
the length of the X [13,14]. In mice, XCI is global in
that it affects nearly all of the 2000 genes or so on
the X chromosome. Once established, the pattern of
XCI is irreversible in the soma.
Throughout the past 40 years, advances in studying
XCI have yielded many surprises. In 1971, Sharman
and colleagues [15,16] described a form of XCI in
marsupials in which the paternal X chromosome is
preferentially inactivated. Paternal-specific X chromo-
some silencing has also been found in extra-embry-
onic tissues of rodent embryos [17,18]. These
discoveries demonstrated for the first time that
genetic information could be unequally expressed in a
manner influenced by its parent of origin. Studies in
the 1990s led to the unprecedented finding that
silencing involves a noncoding, chromatin-associated
RNA [19–21]. In both random and imprinted forms, XCI
is initiated by Xist RNA, a transcript made at the Xic
which then spreads in cis along the X chromosome,
presumably recruiting silencing partners as it accu-
mulates on the future inactive X (Xi) [22,23]. Adding
further to the curiosities of XCI is the discovery that
Xist is regulated in cis by an antisense gene, Tsix [24],
expression of which blocks the accumulation of Xist
RNA along the future active X (Xa) [25–27]. How Xist
RNA ‘paints’ the Xi and how Tsix blocks this
epigenetic ‘painting’ are two of the most compelling
questions in the field.
The study of genomic imprinting has also uncov-
ered many intriguing features. In the 1980s, a series of
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nuclear transfer experiments in mice showed that
maternal and paternal haplo-genomes are not equiva-
lent, and suggested that the mother and father stamp
complementary genetic imprints on their respective
chromosomes [28,29]. As shown by experiments 
of Bruce Cattanach’s group [30] and subsequently by
the identification of numerous imprinted domains
(http://www.mgu.har.mrc.ac.uk/imprinting), a signifi-
cant fraction of the mouse genome is now known to
carry parental imprints which restrict the expression of
one allele. To date, more than 50 genes exhibiting
parent-of-origin effects have been described, but
genetic studies in mice suggest the existence of many
more genes, as well as chromosomal regions, with
parent-of-origin effects (Figure 1). Among the best-
known imprinted genes in mammals are those in the
H19/Igf2 locus, the Prader-Willi and Angelman Syn-
drome complex (PWS/AS), the Beckwith Wiedemann
Syndrome (BWS) locus, the callipyge locus and the
Igf2r/Air locus (see below).
Although imprinted genes serve diverse functions
and are responsible for a wide range of human and
animal diseases, molecular analyses have highlighted
a number of recurrent themes. These include the
propensity of imprinted genes to cluster, the occur-
rence of differentially methylated regions, and the
ubiquity of noncoding and antisense RNAs. Many of
these intriguing features are also found in the Xic.
Together, these remarkable similarities suggest that
genomic imprinting and XCI may share more than
mere co-classification as epigenetic phenomena. At
the end of this review, I propose the contrary idea that
the XCI may have been a major impetus for the evolu-
tion of an imprinting mechanism in mammals.
Molecular Parallels between Imprinting and XCI
Clustering of Genes Subject to Imprinting and XCI
Since the discovery of the first imprinted genes, over
50 have been described in mouse and humans
(http://www.mgu.har.mrc.ac.uk/imprinting). One intrigu-
ing characteristic of nearly all imprinted genes is that
they do not occur isolated in the genome, but rather in
clusters dispersed over large distances (Figure 1)
[8,9,31]. Within the clusters, there appear to be no rules
governing order of gene appearance, direction of tran-
scription or distribution of maternally versus paternally
imprinted genes (Figure 2). Nearly equal numbers of
maternally and paternally imprinted genes have been
reported. Reciprocally imprinted genes can be close
together or far away, and the genes can be transcribed
off the same or opposite DNA strands. Interestingly,
nearly all imprinted clusters studied to date contain at
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Figure 1. Genomic imprinting has become well-fixed in the mammalian genome.
Shown are imprinted gene clusters in the mouse genome (many of these are also found in the human genome). Paternally expressed
genes are red and maternally expressed genes are green. Dark yellow regions indicate imprinted domains. All of the X is shaded pale
yellow to suggest that the entire X is imprinted in some species or tissues. Adapted from http://www.mgu.har.mrc.ac.uk.
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least one maternally expressed and one paternally
expressed gene, and those that do not will probably
turn out on further analysis to show similar clustering.
This type of co-clustering suggests that there may be
a purpose for the grouping of imprinted genes. Other-
wise, one might expect to see clusters in which all
alleles of that cluster are expressed only when trans-
mitted from one parent.
Imprinting takes place on 13 mouse chromosomes
(Figure 1) [30], indicating that imprinting has become
well fixed in eutherian mammals. In some chromo-
somes, the imprinted clusters are quite large. A most
impressive example occurs on mouse chromosome 7,
over which at least four large and independently
regulated clusters can be found. The H19/Igf2 cluster
spans more than 100 kilobases of sequence [32,33]. Its
neighboring Beckwith-Wiedemann Syndrome locus
spans several hundred kilobases and includes Kvlqt1
(which encodes a voltage-gated K channel associated
with long QT syndrome), its antisense counterpart and
p57kip2 [34]. Further up the chromosome is the Peg3
imprinted cluster and the syntenic region of the human
PWS/AS locus [35]. In humans, this locus spans
chromosome 15q11–13, a region of 4 megabases
including more than a dozen imprinted genes. To 
date, ~20 independently regulated imprinted domains
have been identified in the mouse genome (http://
www.mgu.har.mrc.ac.uk/imprinting/all_impmaps.html)
and there are probably a similar number of domains in
the human genome (http://www.genes.uchicago.edu
/upd). Between mouse and human, there appears to
be a nearly perfect conservation of imprinting. One
notable exception is Igf2r, which is imprinted in mice
but not in humans [9,36].
The tendency towards gene clustering is also
apparent in XCI. While we tend to think of XCI as 
a pan-chromosomal phenomenon, not all X-linked
genes are subject to inactivation. On the human X,
genes subject to silencing and those that escape XCI
are blocked into large domains. A first generation X-
inactivation profile estimates that ~10% of the human
X escapes silencing [37,38]. An overwhelming major-
ity of these escapees resides on the short arm (Xp),
accounting for ~35% of the genes on the short arm
and including the pseudoautosomal region as well as
at least two other large clusters. This clustering sug-
gests that regional control elements determine the
transcriptional competence of X-linked genes. Thus,
control of both imprinted and X-linked genes involves
the organization of chromatin into higher-order chro-
mosome structures. How are these domains deter-
mined, and what forces partition the transcriptional
status between domains? Is there a pattern to what
initially appeared to be lack of organization among the
clustered loci? As discussed below, research over the
past 10 years points increasingly to some semblance
of pattern among the disparate loci.
A Plethora of Noncoding and Antisense RNAs
One of the oddest features of imprinted domains and
the Xic is the abundance of noncoding transcripts
(Figure 2). It has been estimated that ~27% of known
human and mouse imprinted genes are noncoding in
nature [9], and many of these have no obvious
function. One of the first discovered is H19 [33] — the
reciprocally imprinted partner of the insulin-like growth
factor 2 locus Igf2 [32] — which is apparently dispens-
able in mice despite its well-conserved nature. In addi-
tion to its sense transcript, the Igf2 locus can produce
a noncoding antisense transcript (Igf2as), the function
of which is also unclear [39]. The critical region associ-
ated with Angelman Syndrome, the E6-AP ubiquitin-
protein ligase locus Ube3a, is paired with a very long
antisense RNA [40] that apparently initiates far down-
stream in the Prader-Willi imprinting center, and is part
of a ‘multicistronic’ RNA precursor that gives rise to
numerous small nucleolar (sno)RNAs [41]. Within the
Beckwith-Wiedemann Syndrome locus, the potassium
voltage-gated channel gene Kvltq1 has a noncoding
antisense RNA partner, Kcqlot1 [42].
One of the best studied autosomally imprinted
antisense genes is Air, which encodes the antisense
transcript of the mouse insulin-like growth factor
receptor 2 locus Igf2r [43]. Air initiates within an
intronic CpG island in Igf2r and is likely transcribed for
more than 108 kilobases off the opposite DNA strand
[44] (Figure 2). Paternal expression of Air RNA is
necessary for cis-silencing of Igf2r and also of two
non-overlapping genes, Slcc22a2 and Slcc22a3, as
shown by the reexpression of the paternal alleles
when the Air CpG island is deleted [43,45]. Recent
work suggests that this antisense repressive mecha-
nism may depend on the RNA, as truncation of the
paternal Air transcript leads to upregulation of all three
maternally expressed Igf2r, Slcc22a2 and Slcc22a3
alleles [46]. Mutations in the maternal Air allele have
no effect at all, consistent with the normal silence of
this allele. Because truncation of Air RNA also affects
the non-overlapping genes, Slcc22a2 and Slcc22a3, it
is proposed that Air RNA may resemble Xist RNA in
that it may ‘paint’ the entire imprinted domain on the
paternal chromosome (in cis). It is also possible,
however, that the transcription of Air may induce
chromatin changes in Igf2r which then spread to
Slc22a2 and Slc22a3.
Considerable effort has been devoted to studying
non-coding genes that lie in and around the Xic. At
least four have been described in mice, including Xist
[19], Tsix [24] and two new transcripts upstream of
Xist named ‘Jpx/Enox’, at –10 kb upstream [47,48],
and ‘Ftx’, at –140 kilobases [47] (Figure 2). So far, 
a regulatory role has been established only for Xist
and Tsix. Genetic evidence indicates that opposing
expression from Xist and Tsix determines which
chromosome will be the Xi and which the Xa. Analysis
of gene knockout mice showed that Xist starts the
silencing process on the Xi [22,23]. Finer mutational
analysis has recently identified a repeat motif at the 5′
end of Xist RNA as the domain responsible for silenc-
ing [49]. Current thinking favors a model in which the
spread of Xist RNA along the X recruits silencing
proteins to that chromosome (reviewed in [50,51]). The
direct targets of Xist RNA have not been identified as
yet, but it is thought that the RNA indirectly recruits to
the Xi the variant histone macroH2A [52] and some
Polycomb group proteins, such as Eed and Ezh2 [53].
The action of Xist is antagonized by Tsix. Tsix
knockout and knock-in analyses showed that the anti-
sense gene blocks the spread of Xist RNA along the X.
In heterozygous (–/+) female embryonic stem (ES)
cells, the choice of which X is inactivated is com-
pletely skewed towards the targeted chromosome, so
that Xist is upregulated only on the chromosome
lacking antisense expression [25,54,55]. Conversely,
when the constitutive EF1α promoter or a tetracycline-
inducible promoter is used to drive high-level and per-
sistent antisense expression from one female X, XCI
can no longer take place on that chromosome,
demonstrating that Tsix transcription is sufficient to
inhibit the action of Xist [26,27].
Throughout the process of XCI, the sense and anti-
sense transcripts have a dynamic pattern of expres-
sion that belies their regulatory relationship [24]. In
undifferentiated female ES cells, Tsix and low-levels of
Xist RNA are expressed on both X chromosomes. This
co-expression suppresses the upregulation of Xist.
During differentiation of female ES cells, Tsix RNA
expression is lost on the presumptive future Xi
chromosome. Intriguingly, Xist RNA is upregulated on
the very X chromosome that has lost Tsix expression,
resulting in the formation of a ‘Xist RNA cloud’ coating
the entire Xi, which might recruit silencing proteins to
that X. On the future Xa, the persistence of Tsix pre-
vents formation of the Xist RNA cloud. Taken together,
these data demonstrate that the two opposing,
noncoding RNAs function in the determination of X
chromosome choice and whether silencing will take
place on each X.
Several possible mechanisms of Tsix action have
been discussed [6]. One school of thought suggests
that antisense transcription is merely incidental and
that Tsix really functions through a region of special-
ized chromatin that acts on Xist at long range. A
second contends that Tsix transcription in the anti-
sense direction provides a repressive force against
Xist. Yet another proposes that Tsix RNA is functional
and titrates out the sense RNA by either enhancing its
degradation or blocking Xist’s silencing domains.
While these models remain to be tested, Tsix overex-
pression studies show that its transcription can block
Xist-induced silencing [26,27]. 
A more recent analysis of Tsix RNA structure and
quantity has further implications for how Tsix works
[56]. Prior to the onset of XCI, Tsix RNA is present at a
10–100-fold molar excess over Xist RNA, consistent
with a model in which Tsix RNA titrates Xist RNA. Only
30–60% of Tsix RNA is spliced at known exon–intron
boundaries — a strange observation in itself, given
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Figure 2. Similarities among imprinted
gene clusters in mice.
Within each cluster, some genes are
omitted for simplicity. ICR, imprinting
control center. Elements shown are not
drawn to scale. The Snurf1/Snrpn/MB11-
85,52,13/Lpw/Ube3a-as transcript begins
at the PWS ICR, is multicistronic, contains
the antisense of Ube3a, and may continue
beyond Ube3a. Atp10c has so far only
been described in human. (See text for
details.)
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that mammalian mRNAs are generally spliced very
quickly and efficiently. Interestingly, although the
splice forms show a high degree of heterogeneity at
the 5′ end, all contain an invariant 3′ exon which is
complementary to Xist’s only known silencing domain
[55,56]. This finding suggests that Tsix might indeed
work as an antisense RNA by annealing to Xist RNA’s
functional domain. Because so much of Tsix remains
unspliced [56], however, a role for full-length Tsix RNA
or its mere transcription cannot be excluded at this
time. Further work at the Xist/Tsix locus, Air and other
imprinted antisense loci will undoubtedly reveal
diverse and highly specialized ways in which anti-
sense genes regulate gene expression.
Differentially Methylated CpG Islands
The Xic and imprinted domains harbor many CpG
islands (Figure 2), short regions of 100–1000 base
pairs that are enriched for the CpG dinucleotide and
which tend to occur at the 5′ regulatory regions of
some mammalian genes [57]. These islands are dis-
tinguished from others in the mammalian genome by
their differentially DNA methylated status on maternal
and paternal alleles. Methylation at the C5 position of
cytosine is known to repress genes by recruiting
methyl-CpG-binding proteins such as MECP2 and
MBD2, which in turn bring histone deacetylases
(HDACs) such as Sin3a and chromatin remodelling
machinery (the NuRD complex) [58]. The importance
of the CpG islands for imprint regulation has been
shown by deletional analysis at several loci, including
H19/Igf2, the PWS/AS locus, the BWS locus and
Igf2r/Air (reviewed in [8]).
The functional importance of DNA methylation has
also been demonstrated by studies of mouse
knockout mutants defective in various DNA methyl-
transferases, which showed that differential methyla-
tion is required to set imprints in the germ line [57].
Loss of Dnmt1 results in mid-gestational lethality, with
embryos exhibiting dysregulation in imprinted gene
expression [59,60]. Dnmt1 is believed to encode the
major ‘maintenance’ methyltransferase, so this result
implies that DNA methylation is required to keep the
maternal and paternal epigenotypes at imprinted loci.
Curiously, Dnmt1 has an oocyte-specific isoform
(Dnmt1o), the maternally-loaded protein product of
which is required during the fourth zygotic S phase to
maintain the maternal pattern of DNA methylation [61].
A sperm-specific promoter is also found in Dnmt1 [57],
and this may direct production of the reciprocal activ-
ity in the paternal germline. A role in imprinting has also
been described for Dnmt 3L, a noncatalytic protein in
the DNA methyltransferase family with sequence simi-
larity to the ‘de novo’ methyltransferases Dnmt3a and
Dnmt3b. Dnmt3L–/– embryos also lack maternal-spe-
cific methylation and die shortly after implantation with
embryonic and extraembryonic abnormalities [62]. The
methylation defect is specific to imprinted regions and
does not affect global DNA methylation. 
Yet another maternal-effect mutation was recently
identified as the cause of a pervasive human imprint-
ing disorder, in which maternal-specific methylation
patterns at multiple discontiguous loci are converted
to the paternal epigenetic pattern [63]. This results in
conceptuses with two paternal epigenotypes that
resemble the classical androgenetic hydatidiform
mole. While the responsible gene has not yet been
pinpointed, preliminary data argue against a mutation
in DNMT3L. The sum of these intriguing findings in
mice and humans clearly demonstrates that parental
imprints are set by the action of germline-specific
DNA methyltransferases on CpG-rich regions in
imprinted domains.
The Xic also contains CpG islands that display
differential methylation. In mice, the 5′ end of Xist
harbors a CpG island which is hypermethylated in
oocytes and undermethylated in sperm [64,65]. This
pattern correlates with preferential Xist expression
from the paternal allele in preimplantation embryos and
in the imprinted extraembryonic tissues of mice, sug-
gesting that differential methylation in the Xist
promoter may be a primary signal governing imprinted
XCI [66]. Consistent with a role for DNA methylation,
male somatic cells lacking Dnmt1 show derepression
of Xist and, in some cells, inappropriate formation of an
Xist RNA cloud on their only X chromosome [67,68].
The extraembryonic tissues, however, appear to be rel-
atively immune to this deficiency of Dnmt1, as XCI still
properly takes place on the paternal X [69]. Upstream
of Xist lies the Jpx/Enox noncoding gene with a CpG
island that apparently remains unmethylated in
somatic cells (no data are available yet on the status in
sperm and oocytes) [47,48]. The functional significance
of this noncoding gene is currently not certain, espe-
cially in light of the finding that at least part of the gene
may be an expressed pseudogene [48].
In the region downstream of Xist lie two other CpG
islands. One is ~15 kilobases upstream of Tsix but
does not appear to play a significant role in XCI,
because its deletion resulted in normal mice with no
anomalies in imprinted or random XCI [55]. A very
prominent island occurs at the 5′ end of Tsix, includ-
ing both its promoter and 2 kilobases of the tran-
scribed region that harbors a repeat element known
as DXPas34 [70]. Deletion of this CpG island results in
completely skewed XCI in somatic cells and a loss of
imprinted XCI in the extraembryonic tissue, indicating
that this region contains a sequence responsible for
the designation of X chromosomes as Xa or Xi [54,55].
In pre-implantation embryos, bisulfite sequencing of
the 1.1 kilobase DXPas34 repeat has not found the
CpG dinucleotides to be differentially methylated,
although the status of remaining CpGs in the large
island has yet to be described [71]. 
The occurrence of multiple CTCF binding sites in
DXPas34 and surrounding unique sequence has led to
the thinking that they act either directly as transcrip-
tional stimulators or indirectly as chromatin insulators
that block Xist from accessing an unidentified
enhancer upstream of Tsix [72]. CTCF protein also
binds to the differentially methylated region of
H19/Igf2 and has been proposed to regulate imprint-
ing by acting as a chromatin insulator against an
enhancer competed for by the two reciprocally
imprinted genes (see below) [73–75]. In light of this
similarity, the possibility that the Tsix CpG island may
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be differentially methylated merits examination
beyond DXPas34. Without differential methylation, the
CpG island may regulate Tsix gene activity through
other chromatin-associated changes.
Cis-Acting Switches
The tight genetic clustering in imprinting and XCI impli-
cate coordinate cis-regulatory regions. In imprinted
regions, epigenetic programs encoded by ‘imprinting
control regions’ (ICRs) are differentially played out on
maternal and paternal chromosomes (Figure 2). In
recent years, putative ICRs have been identified in
many imprinted regions. Evidence for an ICR first
emerged in the Prader-Willi and Angelman Syndromes
loci, two developmental disorders long noted to be
opposite in phenotype — for example, lethargy in PWS
and hyperactivity in AS — which were mapped to con-
tiguous, if not identical, regions of human chromosome
15. Studies in the 1990s led to the identification of
several patients with so-called ‘imprinting defects’ in
which deleting a 4 megabase domain including
2–3 megabases of imprinted genes within the PWS/AS
locus led to a switch from a maternal to a paternal
epigenotype or vice versa [76]. 
It is presently believed that the PWS/AS imprinting
center lies in a 25–30 kilobase region and is composed
of two elements: an 880 base-pair AS center 35 kilo-
base upstream of the Snrpn gene; and a 4.3 kilobase
PWS center at the 5′ end of the Snrpn gene [35]. The
effects of targeted deletions in mice not only support
the designation of these elements as imprinting control
centers but also reveal a complex epistatic relationship
between them. ICRs have been described at several
other imprinted loci, including the Igf2/H19 locus [77],
the Beckwith-Wiedemann syndrome region [34] and
Igf2r/Air [45].
Like imprinting, XCI is also controlled by an
epigenetic switch. Within the Xic, knockout studies
have demonstrated that the switch occurs in an ICR-
like element at the 5′ end of Tsix [54,55] (Figure 2).
Just an ICR, this element is CpG-rich, acts at long
range, and does so only in cis. In the germline, this
element apparently sets the maternal and paternal
epigenotypes, which then direct imprinted XCI in the
extraembryonic tissues. If this element is deleted on
the maternal X, the normally silent Xist allele linked to
the deletion becomes expressed and embryos die
early at the peri-implantation stage, most likely
because of a failure of placenta development.
In tissues that undergo random XCI, this same ICR
element plays a role in X chromosome choice [25].
Deleting this element on one female X results in near
exclusive inactivation of the X chromosome carrying
the Tsix deletion, indicating that it is required to keep
the X active. Deleting the second copy of this element
further alters the choice decision [78]: an excess of
female embryos is lost around the implantation stage,
but surviving female mice show a paradoxical ‘rever-
sion’ to a random pattern of XCI. This reversion does
not reflect a true return to the wild-type state,
however, as it comes at the cost of losing approxi-
mately half of the female embryos. 
Combined, these genetic studies implicate the CpG
island of Tsix as an epigenetic switch that determines
whether the linked Xist gene will be upregulated. The
dual role of this Tsix element in controlling imprinting
and random choice supports the idea that imprinting
and random XCI are evolutionarily linked. Indeed, our
laboratory has postulated that random XCI evolved
from imprinted XCI by relaxing the stringency of
imprinting and by shifting the control of X inactivation
choice from parent to zygote [7,54].
Trans-Allelic Interactions
Tsix genetic studies have shown that, while deleting
one allele of Tsix skews choice completely, deleting
the second allele ‘restores’ the random pattern of XCI.
The mechanism by which XCI choice ‘reverts’ to
random is not known, but the phenomenon is some-
what reminiscent of ‘polar overdominance’, a pattern
of non-Mendelian inheritance in which heterozygosity
(+/–) is phenotypic in a parent-of-origin-specific
manner but homozygosity (–/–) is not. This odd pattern
of inheritance further draws parallels to autosomal
imprinting. In the case of the sheep callipyge locus,
offspring inheriting a callipyge mutation from father
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Figure 3. Mouse XCI and autosomal
imprinting share CTCF binding sites at
the imprinting center.
At the H19/Igf2 locus (left), CTCF binding
to the imprinting control center (ICR)
serves two purposes: chromatin insula-
tion of shared enhancers against Igf2 and
transcriptional activation of H19. At the
Xic (right), the role of CTCF has not yet
been defined. Its position at the 5’ end of
Tsix and the absence (so far) of shared
enhancers for Xist and Tsix make the tran-
scriptional activation model more attrac-
tive than the chromatin insulation model.
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alone exhibit the ‘round buttocks’ phenotype, but
those inheriting the mutation from both parents are
wild type [79]. Polar overdominance at callipyge has
been hypothesized to involve a complex set of trans-
allelic interactions among genes of the imprinted
Dlk1/Gtl2 locus [80].
Similarly, the overdominant phenotype at Tsix has
also been proposed to result from the loss of trans-
interactions. During XCI, the two X chromosomes in
females must coordinate the decision to be inactivated
or remain active — a decision which must involve
some level of chromosome-to-chromosome cross-talk.
From observations on Tsix–/– mice, our laboratory has
hypothesized that the trans-interaction may be medi-
ated by Tsix. In the absence of both Tsix alleles, chro-
mosome choice would be made ‘chaotically’ and
surviving female mice would be those in whom a
majority of cells selected distinct Xs as the Xa and Xi.
Interestingly, trans-allelic cross-talk has also been
proposed for the Prader-Willi/Angelman Syndrome
locus. Cytologic measurements of the human 15p11–13
chromosome region show that the two alleles of the
imprinted domain come together during S phase, sug-
gesting that there may be a specific window during the
cell-cycle when the PWS/AS region might ‘pair’. It is
suggested that homologous pairing at critical periods
may be necessary to establish or maintain the imprinted
pattern of expression [81]. Further, possibility of allelic
cross-talk is also evident at H19/Igf2, where trans-
allelic methylation is seen upon mutation of the CTCF
binding sites in the ICR [82]. The possibility of homol-
ogous trans-interactions would help explain many
aspects of how imprinted regions and the Xics of
female cells are coordinately regulated. It is an idea
that would further unite XCI and autosomal imprinting
and that certainly merits greater investigative effort in
coming years.
CTCF
With the identification of the first cis-acting switches,
many labs have turned their attention to trans-factors
that bind these elements. One recently identified
factor is the CCCTC-binding factor (CTCF), an 11-zinc
finger transcription factor that has been described
variously as an activator, repressor and chromatin
insulator element [83] (Figure 2). Through differential
zinc finger usage, CTCF can bind to a diverse reper-
toire of DNA sequences. One recent breakthrough in
the imprinting field came with the recognition that
CTCF works as a transcriptional switch between H19
and Igf2 by acting as a regulatable chromatin bound-
ary (Figure 3) [73–75]. It was previously shown that,
when the ICR is methylated (paternal chromosome)
Igf2 is expressed, and when it is unmethylated (mater-
nal chromosome) H19 is expressed. In vitro experi-
ments identified four methylation-sensitive CTCF
binding sites within this ICR which modulate the activ-
ity of the ICR. Functional assays in vivo showed that
these CTCF sites have enhancer-blocking activity. 
It is therefore proposed that CTCF and the ICR
together create a chromatin insulator that serves as
an epigenetic switch to regulate the mutually exclu-
sive access of H19 and Igf2 to a set of shared
enhancers. When CTCF binds to the unmethylated
ICR, access of Igf2 to distal enhancers is blocked and
H19 is activated by default. Conversely, when methy-
lation prevents CTCF binding, H19 is bypassed and
Igf2 is activated by the enhancers. Creation of mice
with point mutations in the CTCF binding sites within
the Igf2/H19 ICR leads to loss of enhancer blocking
and Igf2 activation on the mutant maternal chromo-
some [82,84]. Interestingly, maternal H19 expression
is also reduced, suggesting that CTCF may also be a
direct transcriptional activator for H19 in addition to
being a chromatin insulator for Igf2.
In vivo experiments have also demonstrated that
mutating CTCF binding sites within the Igf2/H19 ICR
disrupts maintenance, but not initiation of differential
methylation [84]. This suggests that CTCF does not
set up differential methylation of the ICR in the germ
line, and that something else must carry out this
important role. One candidate factor is the germ cell-
specific paralog of CTCF, named ‘BORIS’ (Brother of
the Regulator of Imprinted Sites) [85]. In contrast to
the ubiquitous expression of CTCF, expression of
BORIS is restricted to primary spermatocytes during
the time of genome remethylation, a time when
resetting of genomic imprints is believed to occur.
Intriguingly, BORIS has a similar DNA-binding domain
as CTCF, suggesting that ICRs in male germ cells may
use BORIS to establish differential methylation or to
‘read’ the differentially methylated codes.
The discovery of potential CTCF sites at other
imprinting centers may speak for generalized conser-
vation of CTCF-mediated imprint regulation. CTCF
motifs have also been identified within a differentially
methylated region of the Dlk1/Gtl2 locus [86] (Figures
2,3). This locus bears striking resemblance to the well-
characterized H19/Igf2 locus. Dlk1 and Igf2 are both
protein-coding genes and are paternally expressed,
while Gtl2 and H19 make noncoding RNAs, which are
both maternally expressed [87]. Furthermore, like H19
and Igf2, Dlk1 and Gtl2 are positioned 80 kilobases
apart in the same relative orientation, and a differen-
tially methylated region is positioned between the
reciprocally imprinted genes [86,87]. Comparative
genomic analysis pinpointed putative CTCF-binding
sites in Gtl2, within one of its introns [86], thus offering
the possibility that CTCF may also function here to
control parent-of-origin-specific expression.
Computational analysis has also led to the
identification of CTCF-binding sites within the imprint-
ing/choice center for X inactivation [72] (Figures 2,3).
In vitro binding assays and in vivo chromatin immuno-
precipitation (ChIP) analysis have both demonstrated
the presence of multiple CTCF-binding sites within the
CpG island of Tsix, in a region that corresponds to a
previously defined repeat called DXPas34. In vitro,
methylation of the Tsix sites prevents CTCF binding.
In stable transfection experiments using reporter
constructs, these CTCF-binding sites can block the
‘cross-talk’ between enhancer and promoter, sug-
gesting that the sites in Tsix may also have chromatin-
insulating activity. 
One possible model is thus that CTCF binds to the
future Xa, preventing Xist transcription by blocking
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communication of Xist with a proposed downstream
enhancer, as has been proposed for CTCF in regulat-
ing H19/Igf2 (Figure 3). But shared enhancer elements
have not yet been found for Xist/Tsix, and the location
of CTCF sites within the Tsix gene body may not be
optimal for an enhancer-blocking mechanism. Given
CTCF’s position at the 5′ end of Tsix, we must also
consider the possibility that CTCF works as a direct
transcriptional activator or enhancer of the antisense
gene. Although methylation blocks CTCF binding in
vitro, whether DNA methylation might regulate its
binding in vivo remains unclear, as conflicting evi-
dence has been reported for the methylation status of
the DXPas34 region [71,88]. As some CTCF binding
sites occur outside of the region examined in these
past studies, one future aim will be to determine the
methylation status of sequence surrounding DXPas34.
The extent to which CTCF-mediated mechanisms are
conserved between X inactivation and autosomal
imprinting will be of major interest.
Allele-Specific Differences in Chromatin
Composition
Although DNA methylation is instrumental in estab-
lishing and maintaining expression patterns of epige-
netically regulated genes, it is not the only determinant.
Changes in chromatin composition have also been
shown to play a role. Variant histones, such as
macroH2A, show differential enrichment patterns on
the Xa and Xi. This phenomenon was the subject of
recent reviews [50,51] and will not be further discussed
here. Instead, I will focus on differential histone modi-
fication and the roles of non-histone proteins, areas in
which there has been a recent explosion in progress
towards understanding XCI and autosomal imprinting.
Differential histone modification has emerged as 
a common feature between XCI and autosomal
imprinting, the most topical of late being histone H3
methylation. In general, methylation of lysine 4 (K4) on
H3 has been associated with gene activation, while
methylation of lysine 9 (K9) on H3 is associated with
heterochromatin [89]. During XCI, differences in
acquisition of H3 methylation and acetylation are
characteristic of the Xi and Xa. The Xi is hypoacety-
lated on the amino-terminal lysines of nearly all core
histone proteins [90], hypomethylated on H3 K4, and
hypermethylated on H3 K9 [91–94]. These histone tail
modifications first appear around, or shortly after, the
accumulation of Xist RNA along the X, suggesting that
they are one of the first responders of the epigenetic
program established by parental imprinting or zygotic
choice. It is perhaps interesting to note that H3 K9
methylation on the inactive X has not yet been associ-
ated with HP1 recruitment (HP1 recruitment seems to
be a general occurrence on other types of H3-hyper-
methylated heterochromatin) [92]. These modifications
are some of the earliest changes to occur after the
spread of Xist RNA occurs along the Xi, suggesting
that they are one of the earliest responders to ‘lock in’
the inactive state as dictated by upstream epigenetic
signals. One study indicates that a hotspot for H3-K9
methylation occurs ~50 kilobases upstream of Xist
and is present before the onset of XCI [93], leaving
open the possibility that histone modification may also
play a role in setting up the epigenetic program.
Autosomally imprinted loci have also been shown to
exhibit differential histone tail modifications between
alleles. The Prader-Willi/Angelman Syndrome locus
contains a bipartite imprinting center which regulates
parent-of-origin-specific expression pattern genes
along the 2–4 megabase region in a cis-limited fashion
[35]. It is believed that the AS-SRO — the shortest
region of overlap for the AS imprinting center — fires
only on the maternal chromosome, thereby enabling
maternal-specific expression of UBE3A and ATP10C.
On the paternal chromosome, the PWS-SRO fires and
allows for expression of numerous paternal-specific
transcripts in cis. Recent work has shown that the AS-
SRO is hypermethylated on H3 K4 and hyperacetylated
H4 only on the active maternal allele, and that it likely
represses the activity of the PWS-SRO in cis, possibly
setting up the observed differential sensitivity to DNaseI
at the PWS-SRO [95]. Allele-specific differences in H3
methylation and acetylation also occur on Igf2r and
U2af1-rs1 in mice [96]. Therefore, differential histone
modifications may be yet another unifying feature of X-
linked and autosomally imprinted loci.
Differential chromatin states on epigenetically
regulated loci also involve recruitment of non-histone
proteins. Several intriguing non-histone proteins have
been associated with the Xi. Polycomb group proteins
have emerged as repressors of X-linked gene expres-
sion and downstream effectors of Xist RNA-mediated
silencing. In mice, the Eed protein is required to main-
tain imprinted silencing of the paternal X in extraem-
bryonic tissues. Embryos lacking Eed die after
implantation, partly because of reactivation of the
previously silent paternal X [97]. By immunofluores-
cence, Eed and another Polycomb group protein,
Ezh2, have been shown to be enriched on the Xi in
trophoblast stem cells [53]. The similar ‘painting’
pattern of Eed, Ezh2 and Xist RNA has led to specula-
tion that the two Polycomb group proteins may be one
of the immediate downstream targets of Xist RNA.
Interestingly, Ezh2 contains a SET domain and has
been shown to be an H3-K27, and likely also an H3-
K9, methyltransferase in Drosophila and mammals
[98–101]. Given the H3-K9 hypermethylation on the Xi,
it is tempting to speculate that Ezh2 may be the
enzyme responsible for this epigenetic mark, espe-
cially given that genetic analysis has shown that the
H3-K9 methyltransferases Suv39-h1 and h2, responsi-
ble for methylation at other heterochromatic loci, are
not responsible for XCI [92]. Polycomb group proteins
may also regulate imprinting on autosomes. Com-
pound Eed heterozygotes carrying one null and one
hypomorphic allele show ectopic Mash2 expression,
suggesting that Eed may play some role in either 
the establishment or maintenance of autosomally
imprinted genes [97]. So Polycomb proteins may have
repressive roles in both XCI and autosomal imprinting.
Finally, an intriguing connection between XCI and
the breast tumor suppressor gene product BRCA1 was
recently made [102]. Working from the classical obser-
vation that many human breast cancer cell lines lack a
‘Barr body’ — a region of condensed chromatin on the
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Xi — the study shows that BRCA1 protein co-localizes
with the inactive X in 5–10% of female cells, predomi-
nantly in cells going through S phase. Absence of the
Brca1 protein in mouse cells results in loss of Xist RNA
localization to the X. RNA interference (RNAi) knock-
down of Brca1 has the same effect, and complemen-
tation of Brca1–/– cells by a Brca1 transgene restores
the Xist RNA paint. Despite the association of Brca1
with the Xi, the loss of BRCA1 and Xist RNA paint does
not actually derepress X-linked genes, as indicated by
the lack of substantial reactivation of an X-linked GFP
marker. This observation suggests that Brca1 protein
may not play a role in maintenance of XCI, but may
instead be involved in some other aspect of the Xi
chromosome structure. Nonetheless, the connection
made between a tumor suppressor and XCI opens up
the possibility that other cancer-related genes may be
involved and that similar genes may be involved in
autosomal imprinting.
Taken together, this explosion of recent discoveries
argues that similar chromatin effectors are recruited
by the Xic and autosomal imprinting centers. More
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Figure 4. The proposed hypothesis that autosomal imprinting evolved from dosage compensation in mammals.
(A) In the current view of mammalian evolution, the fixation of maleness genes on the Y chromosome (X′) was accompanied by piece-
meal degeneration of the Y chromosome (X′), a process most evident in metatherians. The degeneration of the Y left many X-linked
genes without Y homologues. This dosage imbalance therefore necessitated a dosage compensation mechanism, which — in the
case of mammals — led to the evolution of an X-inactivation mechanism for affected chromosome segments. It is proposed here that
this pressure led to the evolution of an imprinting mechanism in mammals for the first time.  This imprinting mechanism was later
transposed to or duplicated on autosomes to deal with other biological problems (see text). (B) Because the paternal X can only be
transmitted to daughters, and dosage compensation is necessary only in the female, an imprinting mechanism for silencing the pater-
nal X would have solved the problem of dosage compensation without the need to evolve a counting mechanism at the same time.
In eutherians, the acquisition of a counting mechanism enabled species to ‘relax’ imprinted XCI and to evolve a ‘random’ mechanism
for XCI (see panel A). X, X chromosome; X′, newly formed Y chromosome prior to loss of genetic material; Y, Y chromosome, A,
generic autosome. ‘M’ and ‘P’ subscripts designate the maternally and paternally inherited chromosomes, respectively.
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chromatin-associated factors will no doubt come to
light. Some, like BRCA1, may come from areas far
afield. Furthermore, as mysteries of the histone code
continue to unravel, differential histone modification
will probably expand to include other types of modifi-
cation; in addition to methylation and acetylation,
phosphorylation and ubiquitylation are possibilities
that merit consideration.
X Chromosome Inactivation as an Evolutionary
Impetus for Genomic Imprinting
Why genomic imprinting evolved is an often asked
question with many well-argued theories. Imprinting
clearly arose independently many times during evolu-
tion, as it is seen today in organisms as diverse as
plants [103] and mammals [8]. Recent studies show
that imprinting arose in early mammals some 120–150
million years ago [104,105]. Haig [106] has argued that
genomic imprinting in mammalian development
reflects the proverbial tug-of-war between parents in
polygamous species. This hypothesis arises from the
observation that many paternally expressed genes
enhance fetal growth, while maternally expressed
genes suppress growth. The idea is that, because one
female can potentially mate with many males, each
male attempts to maximize the growth and survival of
his offspring by promoting his offspring’s growth,
while each female tries to restrict and balance the
growth among all her offspring. 
Two other attractive models postulate that im-
printing first arose to deal with maternal–fetal toler-
ance [9] or to foster placental development [107].
Indeed, among vertebrates, imprinting is so far only
known to occur in marsupial and eutherian mammals,
both of whose fetuses spend at least some time in
intra-uterine gestation. Theoretically, by silencing
paternally expressed histocompatibility genes, the
fetus would minimize detection by the maternal
immune system. However, paternally silenced histo-
compatibility genes have not been identified. Still
others argue that imprinting arose to prevent par-
thenogenesis by necessitating contributions from both
parents [28,29,31]. Another hypothesis posits that
imprinting is merely a manifestation of a capricious
epigenetic arms race and is not necessary for devel-
opment or evolution at all [108]. Finally, the idea that
imprinting might have evolved as one way to effect
sex-specific X-linked gene expression has also been
advanced [109]. Diverse as they are, these hypotheses
are not mutually exclusive and all may have played
some role in the evolution of imprinting.
It is interesting to note that autosomal imprinting is
often treated as a mechanism distinct from XCI
(summaries at http://www.mgu.har.mrc.ac.uk/imprint-
ing; http://www.genes.uchicago.edu/upd). However,
several investigators long noted the striking similari-
ties between these two epigenetic phenomena
[30,110–112]. In light of numerous molecular parallels,
the idea that X chromosome inactivation and autoso-
mal imprinting are related at the mechanistic level is
now beyond question. To what extent and whether
there might be an even deeper connection remain
unanswered. I would like to propose a novel
approach to thinking about the link between XCI and
autosomal imprinting.
I pose the question: might X chromosome inactiva-
tion have provided a major impetus for the evolution of
genomic imprinting in early mammals (Figure 4A)? It is
believed that mammals arose some 200 million years
ago from lizard-like creatures known as synapsids,
which appear to have neither XCI nor imprinting
[112,113]. Included in this extant group are the pro-
totherians (monotremes, considered to be the earliest
mammalian lineage), the metatherians (marsupials) 
and eutherians (placental mammals). XCI has been
observed in both metatherians and eutherians, in which
the X and Y chromosomes are unequal in size and gene
content (reviewed in [112,113]). XCI has not been
observed so far in prototherians, in which the sex chro-
mosomes appear equally sized [114]. The monotreme-
to-metatherian transition was accompanied by a
large-scale ‘degeneration’ of the Y chromosome. This
diminution of the Y must have necessitated the simul-
taneous evolution of a ‘dosage compensation’ mecha-
nism to deal with the imbalance of X-linked genes
between XX and XY individuals [115]. 
As noted earlier [111,112], X chromosome inac-
tivation in its earliest form might have been very local-
ized. It may have been restricted to contiguous genes
on the X, the dosage of which must be precisely reg-
ulated during development, or to those genes whose
Y homologues have been lost. The silencing phenom-
enon might have spread along the X in a piecemeal
fashion over time as the Y chromosome continued to
lose genetic material. In metatherians (marsupials),
evolutionary evidence indicates that this early form of
XCI was indeed imprinted to occur on the paternal X
[15], and occurs to a variable extent along that X in
different tissues [114].
I argue that, as only female offspring can inherit the
paternal X, adopting an imprinted silencing mech-
anism for the paternal X would have solved the
problem of dosage compensation without the need to
simultaneously evolve an X chromosome counting
mechanism (Figure 4A,B). Although very little is
presently known about how counting takes place,
counting is believed to involve a complex mechanism
of measuring the X-to-autosome ratio, so its evolution
would have in itself been a very demanding process.
By proposing that dosage compensation drove the
evolution of imprinting, I do not mean that noncoding
RNAs, antisense transcripts, CTCF and the other dis-
cussed elements originated at the Xic. This is almost
certainly not the case — I suspect that these elements
were already established in mammalian ancestors and
synapsids for purposes other than XCI or imprinting.
What I postulate is that the Xic may have been one of
the first to integrate these disparate elements and
that, in doing so, established the earliest mechanism
of genomic imprinting in mammals. This hypothesis
benefits from the fact that dosage compensation was
a very real evolutionary force during the early course
of mammalian radiation.
Once imprinting was fixed on the X, I suggest that
the molecular machinery was co-opted by autosomes
to deal with various biological challenges on a more
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localized scale (Figure 4A). These challenges may
include any of those previously proposed by others,
such as dosage regulation in maternal–paternal
conflicts [106], fixation of sexual reproduction (anti-
parthenogenesis theory [28,29]), establishment of
maternal–fetal tolerance [9] and acquisition of further
ammunition for the epigenetics arms race [108]. The
acquisition of imprinting by autosomes may initially
involve a transposition or duplication event that
imports elements at the Xic — such as non-coding
RNAs, CTCF and cis-acting switches — for such
novel purposes. The model predicts that transposi-
tion or duplication occurred repeatedly over the
course of evolution, either from the original X-linked
locus or subsequently from autosomal loci that have
them-selves already acquired imprinting. One likely
case of autosomal duplication involves H19/Igf2
(mouse chromosome 7) and Dlk1/Gtl2 (mouse chro-
mosome 12), for which the strikingly similar genetic
organization implicates a very recent shared origin
(Figure 2). It is envisioned that imprinting elements
would evolve continually at each locus to adapt to its
particular needs. Such a model would explain why
XCI and autosomal imprinting share many molecular
features at the same time that they are unique in mol-
ecular details.
On the X chromosome, a relaxation of imprinting to
a stochastic mechanism appears to have occurred
subsequently during the metatherian-to-eutherian
transition (Figure 4A). This step towards random
choice is teleologically advantageous to the species
and evolutionarily beneficial for the female, as it not
only provides greater phenotypic variation for the
species but also lessens the impact of deleterious
maternal X-linked mutations on the female offspring.
This progression from imprinted to random XCI must
have been accompanied by the evolution of an X
chromosome counting mechanism that enables the
developing zygote to determine whether it has the
need for dosage compensation (XX versus XY). Theo-
retically, by evolving an imprinted form of dosage
compensation first, early mammals postponed the
problem of X chromosome counting for its evolution-
ary descendants.
Admittedly, the available molecular and evolution-
ary evidence cannot distinguish among the evolution-
ary model proposed here and those proposed
previously by others. Notably, autosomal imprinting
appears to have evolved around the same time as and
not before XCI — both are already present in metathe-
rians [104,105,112,113]. But because neither has so
far been described in monotremes, the question of
which came first — XCI or autosomal imprinting —
cannot be answered at this time. For the reasons
stated, the model proposed here has the advantage of
invoking a very real and strong evolutionary pressure
as the driving force for establishment of an imprinting
mechanism. Ultimately, only by looking back in time
can we piece together answers to this compelling
question. Fortunately, several species of monotremes
and marsupials still exist today. Detailed investigation
of the character of dosage compensation and autoso-
mal imprinting in extant mammalian ancestors will be
essential for solving the problem of why and how
gametic imprinting evolved in mammals.
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